Raffles Medical Group

SINGAPORE (May 2): RHB is downgrading its call on Raffles Medical Group (RMG) to “sell” from “neutral” with an unchanged $1.02 target price.

SINGAPORE (Oct 30): Raffles Medical Group (RMG) announced that 3Q17 earnings increased 1.0% to $16.4 million compared to $16.2 million in 3Q16.

SINGAPORE (Aug 1): RHB and Maybank Kim Eng are downgrading their call on Raffles Medical Group to “sell” with target prices of $1.10 and $1.12 respectively.

SINGAPORE (June 19): UOB Kay Hian is remaining “market weight” on Singapore’s healthcare sector on expectations of decelerating medical tourism growth in Singapore, due to rising competition from neighbouring Asean countries such as Malaysia. 

SINGAPORE (May 22): Healthcare stocks in Singapore have rewarded investors with an average 50% gain in the past year, a rally that may continue as companies acquire local clinics to expand in the region’s medical-care market.

SINGAPORE (April 24): Raffles Medical Group posted relatively flat 1Q earnings of $15.5 million, just 0.1% higher than a year ago.

SINGAPORE (April 20): OCBC Investment Research is remaining “neutral” on Singapore’s healthcare sector on the observation that China remains an attractive choice for growth among local private healthcare companies despite challenges abound.

SINGAPORE (April 3): Raffles Medical Group (RMG) has acquired a 28,000 sq m plot of land in the New North District of the Liangjiang New Area in Chongqing, China, on which it intends to develop a 700-bed international tertiary general hospital.

SINGAPORE (March 29): Maybank Kim Eng Research is reiterating its “buy” call on Raffles Medical Group at an unchanged price target of $1.70, after having hosted the private healthcare provider at its recent Invest ASEAN Singapore Conference.

SINGAPORE (March 21): UOB Kay Hian believes that the benchmark FTSE Straits Times Index (STI) looks fairly valued after rising 9.9% year-to-date to sit above the brokerage’s year-end target of 3,050.